Market conditions do not yet allow Binnopharm Group to hold an IPO, but the company does not abandon these plans, said Felix Evtushenkov, who owns 15.2% of the corporation. No predictions are made as to when it will be possible, he said. Earlier Rustem Muratov, General Director of Binnopharm Group, also said that the company was studying the possibility of an IPO not only on the Russian but also on one of Asian stock exchanges.